Converting enzyme activity in regulation of blood pressure and kidney function. A review.
D000804:Angiotensin II / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy / Q000201:enzymology*; D006978:Hypertension, Renovascular / Q000188:drug therapy / Q000201:enzymology; D007677:Kidney Function Tests; D007703:Peptidyl-Dipeptidase A / Q000097:blood*; D051381:Rats; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000187:drug effects; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D006852:Hydrochlorothiazide; D000804:Angiotensin II; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; D012083:Renin